The critically ill patient very often presents with systemic evidence of infection including tachypnea, tachycardia and hypo-hyperthermia; this may lead to sepsis syndrome and subsequent multisystem organ failure. In order to manage this clinical condition, nutritional supportive therapy is very often required. The choice between enteral and parenteral nutrition is not always straightforward. Early enteral nutrition seems to exert beneficial effects, although parenteral nutrition is often easier to administer, and thus is the treatment of choice. There are only few prospective, randomized, controlled trials comparing the two methods of intervention therapy. Parenteral nutrition seems to be associated with mechanical, metabolic and septic complications, while enteral nutrition, which is associated with similar complications, prevents gastrointestinal mucosal atrophy, attenuates the injury stress response, maintains immunocompetence, and preserves normal gut flora. This literature review focuses on the role played by these two methods of nutritional support therapy in the development of systemic infections. This review will also analyze possible mechanisms of action and future therapeutic strategies.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.